Handle With Care: Black Diamond Therapeutics Inc (NASDAQ: BDTX)
Currently, there are 56.64M common shares owned by the public and among those 43.16M shares have been available to trade. The company’s stock has a 5-day price change of 0.60% and -22.83% over the past three months. BDTX shares are trading -21.03% year to date (YTD), with the 12-month market performance down to -68.76% lower. […]
There Is Clear Momentum For Black Diamond Therapeutics Inc (NASDAQ: BDTX)
Black Diamond Therapeutics Inc (BDTX) concluded trading on Thursday at a closing price of $1.88, with 22.06 million shares of worth about $41.48 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -61.04% during that period and on March 20, 2025 the price saw […]
Black Diamond Therapeutics Inc (NASDAQ: BDTX): Hunting Genuine Value In Market Debris
Bellevue Asset Management AG recently announced the acquisition of new stake in Black Diamond Therapeutics Inc (NASDAQ:BDTX). The institutional investor has increased its shareholding in the Healthcare company by 4.70% to 8.52 million shares with purchase of 0.38 million shares. This fresh investment now brings its stake to 16.50% valued currently at $23.94 million. In […]
Value Hunters: Look To Black Diamond Therapeutics Inc (BDTX)
Bellevue Asset Management AG recently announced the acquisition of new stake in Black Diamond Therapeutics Inc (NASDAQ:BDTX). The institutional investor has increased its shareholding in the Healthcare company by 4.70% to 8.52 million shares with purchase of 0.38 million shares. This fresh investment now brings its stake to 16.50% valued currently at $19.93 million. In […]
